This learning program is designed to introduce a type of leukemia known as acute lymphoblastic leukemia or acute lymphocytic leukemia also referred to as ALL. ALL is caused by the rapid overproduction of lymphoblasts which are immature white blood cells from the lymphoid lineage. This learning program first covers the epidemiology of ALL. The pathophysiology diagnosis staging and prognosis of the disease are then reviewed
Upon completion of this learning program you will be able to::
Recall key information about the ALL treatment guidelines.
Recall the specifics of the ALL treatment environment.
Discuss the assessment of response to ALL treatment.
Describe the treatment pathways in pediatric ALL patients.
Describe the treatment pathways in adult ALL patients.
List the complications that can arise during ALL treatment and describe their management.
EPIDEMIOLOGY OF ALL
INCIDENCE AND PREVALENCE
ALL IN CHILDREN
ALL IN CHILDREN (CONTINUED)
PATHOPHYSIOLOGY OF ALL
MALIGNANT TRANSFORMATION OF LYMPHOID STEM CELLS
LYMPHOBLASTIC PROLIFERATION IN OTHER ORGANS
LYMPHOBLASTIC PROLIFERATION IN THE CNS
DIAGNOSIS OF ALL
DIFFERENTIAL DIAGNOSIS (CONTINUED)
DEFINITIVE DIAGNOSTIC TESTS
DEFINITIVE DIAGNOSTIC TESTS (CONTINUED)
IMMUNOPHENOTYPING AND CYTOGENETIC ANALYSES
IMMUNOPHENOTYPING AND CYTOGENETIC ANALYSES (CONTINUED)
IMAGING STUDIES IN ALL
STAGING AND PROGNOSIS OF ALL
STAGING OF ALL
LEUKEMIA OF AMBIGUOUS LINEAGE
CLINICAL PROGNOSTIC FACTORS
TREATMENT-RELATED PROGNOSTIC FACTORS
TREATMENT-RELATED PROGNOSTIC FACTORS (CONTINUED)
TEST YOUR ACQUIRED KNOWLEDGE
END OF PROGRAM
This course is accredited for continuing education (CE) by the following organizations:
Australian Nursing & Midwifery Federation
CPD Hours: 1